| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $178.0M | +195.3% |
| Cost of Revenue | $70K | — |
| R&D Expense | $149.1M | +17.8% |
| SG&A Expense | $87.3M | +18.7% |
| Operating Income | -$68.8M | +50.8% |
| Pre-tax Income | -$67.2M | +40.3% |
| Income Tax | $3.6M | +167.7% |
| Net Income | -$70.8M | +37.8% |
| EPS (Basic) | -$0.05 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $91.1M | -36.7% |
| Accounts Receivable | $1.5M | +77.1% |
| Inventory | $7.3M | — |
| Current Assets | $188.2M | -9.3% |
| Total Assets | $246.0M | -13.0% |
| Current Liabilities | $64.5M | -11.3% |
| Long-term Debt | $54.3M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.2M | +48.0% |
| Capital Expenditures | $886K | -81.1% |
| Investing Cash Flow | -$59.0M | -133.4% |
| Financing Cash Flow | $78.7M | +8848.8% |
| Free Cash Flow | -$74.1M | +49.1% |
| +44.4% |
| EPS (Diluted) | -$0.05 | +44.4% |
| Total Liabilities |
| $234.1M |
| -3.7% |
| Stockholders' Equity | $11.8M | -70.0% |